119 related articles for article (PubMed ID: 37685768)
1. The Natural History and Management of Hepatic Hemangioma.
Maruyama S; Matono T; Koda M
J Clin Med; 2023 Sep; 12(17):. PubMed ID: 37685768
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and Characteristics of Hepatic Hemangioma Associated with Coagulopathy and Its Predictive Risk Factors.
Maruyama S; Matono T; Koda M
J Clin Med; 2022 Jul; 11(15):. PubMed ID: 35893437
[TBL] [Abstract][Full Text] [Related]
3. Association of tumor size and internal echo pattern with coagulopathy associated with hepatic hemangioma.
Maruyama S; Koda M; Matono T; Isomoto H
Mol Clin Oncol; 2021 Apr; 14(4):83. PubMed ID: 33758664
[TBL] [Abstract][Full Text] [Related]
4. New recognition of the natural history and growth pattern of hepatic hemangioma in adults.
Jing L; Liang H; Caifeng L; Jianjun Y; Feng X; Mengchao W; Yiqun Y
Hepatol Res; 2016 Jul; 46(8):727-33. PubMed ID: 26492419
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and Prognostic Value of TAT, PIC, TM, and t-PAIC in Malignant Tumor Patients With Venous Thrombosis.
Zhou K; Zhang J; Zheng ZR; Zhou YZ; Zhou X; Wang LD; Suo B; Jiang XF; Liu PJ; Wang DH
Clin Appl Thromb Hemost; 2020; 26():1076029620971041. PubMed ID: 33141604
[TBL] [Abstract][Full Text] [Related]
6. Natural History of Hepatic Hemangiomas Larger Than 10 cm: Imaging Findings and Clinical Course of 22 Cases.
Onishi Y; Ohno T; Shimizu H; Shimada K; Isoda H; Ishii T; Takai A; Nakamoto Y
Cureus; 2023 Dec; 15(12):e50563. PubMed ID: 38226088
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous evolution patterns of focal congenital hepatic hemangiomas: a case series of 25 patients.
Rutten C; Ladarre D; Ackermann O; Gonzales E; Guettier C; Franchi-Abella S
Pediatr Radiol; 2022 May; 52(6):1048-1060. PubMed ID: 35229180
[TBL] [Abstract][Full Text] [Related]
8. [Follow-up study of hepatic hemangiomas].
Kobayashi T; Kawano M; Tomita Y; Tamano T; Saegusa S; Horinaka M; Monma T; Oguma M; Yanagisawa N; Ohe T
Nihon Shokakibyo Gakkai Zasshi; 1995 Jan; 92(1):41-6. PubMed ID: 7861625
[TBL] [Abstract][Full Text] [Related]
9. Assessing normal growth of hepatic hemangiomas during long-term follow-up.
Hasan HY; Hinshaw JL; Borman EJ; Gegios A; Leverson G; Winslow ER
JAMA Surg; 2014 Dec; 149(12):1266-71. PubMed ID: 25321079
[TBL] [Abstract][Full Text] [Related]
10. [Coagulation tests in septic surgical patients].
Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
[TBL] [Abstract][Full Text] [Related]
11. Hepatic resection of giant cavernous hemangioma of the liver.
Hanazaki K; Kajikawa S; Matsushita A; Monma T; Koide N; Nimura Y; Yazawa K; Watanabe H; Nishio A; Adachi W; Amano J
J Clin Gastroenterol; 1999 Oct; 29(3):257-60. PubMed ID: 10509952
[TBL] [Abstract][Full Text] [Related]
12. [Changing characteristic of blood coagulation factors and their correlation with blood coagulation status in different hepatic diseases].
Chen J; Duan ZP; Bai L; Zhao J; Ding M; Tong XY; Cong YL
Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):206-10. PubMed ID: 22475141
[TBL] [Abstract][Full Text] [Related]
13. [Study on the value of prothrombin time for predicting the severity and prognosis of septic patients].
Bai H; Shen L; Jing L; Liu W; Sun Z; Tang N
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jul; 34(7):682-688. PubMed ID: 36100403
[TBL] [Abstract][Full Text] [Related]
14. Hepatic cavernous hemangiomas: long-term (> 5 years) follow-up changes on contrast-enhanced dynamic computed tomography or magnetic resonance imaging and determinant factors of the size change.
Choi J; Yu JS; Cho ES; Kim JH; Chung JJ
Radiol Med; 2018 May; 123(5):323-330. PubMed ID: 29357040
[TBL] [Abstract][Full Text] [Related]
15. Higher prognostic value of soluble fibrin complexes than D-dimer and fibrin degradation product for disseminated intravascular coagulation in patients with liver cirrhosis.
Kim SY; Kim JE; Kim HK; Kim I; Yoon SS; Park S
Blood Coagul Fibrinolysis; 2013 Mar; 24(2):150-6. PubMed ID: 23314386
[TBL] [Abstract][Full Text] [Related]
16. Hypergiant hepatic hemangiomas: case series.
Adhikari DR; Thakur V; Telavane PP; Kulkarni R; Singh R; Joshi RM
Indian J Surg; 2015 Apr; 77(Suppl 1):40-2. PubMed ID: 25972639
[TBL] [Abstract][Full Text] [Related]
17. High F1.2 fragment of prothrombin, thrombin-antithrombin III complex (TAT) and soluble fibrin plasma levels demonstrate hypercoagulability induced during loco-regional thrombolytic therapy with rt-PA.
Garcia-Avello A; Garcia-Frade LJ; Gandarias C; Ocaña J; Cancelas JA; Lasso M
Thromb Res; 1994 Jan; 73(2):109-15. PubMed ID: 8171409
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation for large hepatic hemangiomas: initial experience and lessons.
Gao J; Ke S; Ding XM; Zhou YM; Qian XJ; Sun WB
Surgery; 2013 Jan; 153(1):78-85. PubMed ID: 22853860
[TBL] [Abstract][Full Text] [Related]
19. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
[TBL] [Abstract][Full Text] [Related]
20. Incidence and clinical significance of elevated fibrin(ogen) degradation product and/or D-dimer levels in liver cirrhosis patients.
Cioni G; Cristani A; Mussini C; Grandi S; Pentore R; Zeneroli ML; Tizzanini W; Zagni G; Ventura E
Ital J Gastroenterol; 1990 Apr; 22(2):70-4. PubMed ID: 2131934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
